Abstract:Angiogenesis contributes fundamentally to embryonic development, tissue homeostasis, and wound healing. Basic fibroblast growth factor (FGF2) is recognized as the first proangiogenic molecule discovered, and it facilitates angiogenesis by activating FGF receptor 1 (FGFR1) signaling in endothelial cells. However, the precise roles of FGFR and the FGF/FGFR signaling axis in angiogenesis remain unclear, especially because of the contradictory phenotypes of in vivo FGF and FGFR gene deficiency models. Our previous study results suggested a potential role of posttranslational small ubiquitin-like modifier modification (SUMOylation), with highly dynamic regulatory features, in vascular development and disorder. Here, we identified SENP1-regulated endothelial FGFR1 SUMOylation at conserved lysines responding to proangiogenic stimuli, while SENP1 functioned as the deSUMOylase. Hypoxia-enhanced FGFR1 SUMOylation restricted the tyrosine kinase activation of FGFR1 by modulating the dimerization of FGFR1 and FGFR1 binding with its phosphatase PTPRG. Consequently, it facilitated the recruitment of FRS2α to VEGFR2 but limited additional recruitment of FRS2α to FGFR1, supporting the activation of VEGFA/VEGFR2 signaling in endothelial cells. Furthermore, SUMOylation-defective mutation of FGFR1 resulted in exaggerated FGF2/FGFR1 signaling but suppressed VEGFA/VEGFR2 signaling and the angiogenic capabilities of endothelial cells, which were rescued by FRS2α overexpression. Reduced angiogenesis and endothelial sprouting in mice bearing an endothelial-specific, FGFR1 SUMOylation-defective mutant confirmed the functional significance of endothelial FGFR1 SUMOylation in vivo. Our findings identify the reversible SUMOylation of FGFR1 as an intrinsic fine-tuned mechanism in coordinating endothelial angiogenic signaling during neovascularization; SENP1-regulated FGFR1 SUMOylation and deSUMOylation controls the competitive recruitment of FRS2α by FGFR1 and VEGFR2 to switch receptor-complex formation responding to hypoxia and normoxia angiogenic environments.

Fringe is a glycosyltransferase that modifies Notch

Fringe Modifies O-fucose on Mouse Notch1 at Epidermal Growth Factor-Like Repeats Within the Ligand-Binding Site and the Abruptex Region.

Notch Ligands Are Substrates for Protein O-Fucosyltransferase-1 and Fringe

Fringe: Defining Borders by Regulating the Notch Pathway.

Protein O -Fucosyltransferase 1 is an Essential Component of Notch Signaling Pathways

FGFR1 SUMOylation Coordinates Endothelial Angiogenic Signaling in Angiogenesis

O-fucose monosaccharide of Drosophila Notch has a temperature-sensitive function and cooperates with O-glucose glycan in Notch transport and Notch signaling activation

Roles of Pofut1 and O-fucose in Mammalian Notch Signaling.

Structural and functional studies of the EGF20-27 region reveal new features of the human Notch receptor important for optimal activation

A TargetedIn VivoRNAi Screen Reveals Deubiquitinases As New Regulators of Notch Signaling

The fringe molecules induce endocrine differentiation in embryonic endoderm by activating cMyt1/cMyt3.

Structural Basis of Notch O-glucosylation and O–xylosylation by Mammalian Protein–o-Glucosyltransferase 1 (POGLUT1)

Chi and dLMO function antagonistically on Notch signaling through directly regulation of fng transcription

Notch-Jagged signaling complex defined by an interaction mosaic

Drosophila Rtf1 functions in histone methylation, gene expression, and Notch signaling

Notch pathway repression by vestigial is required to promote indirect flight muscle differentiation in Drosophila melanogaster

Notch signalling: a simple pathway becomes complex

The Secreted Product of Xenopus Gene Lunatic Fringe, a Vertebrate Signaling Molecule

Structural basis of frizzled 7 activation and allosteric regulation

Recognition of EGF-like Domains by the Notch-modifying O-fucosyltransferase POFUT1

Neural-specific α3-fucosylation of N-linked glycans in the Drosophila embryo requires fucosyltransferase A and influences developmental signaling associated with O-glycosylation.